Tedizolid
CAS 856866-72-3 7 FDA-DMF suppliersSmall Molecule
Overview
Tedizolid is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1257051).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Tedizolid expires 31 Dec 2030 and exclusivity 3 Apr 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)-3-pyridinyl]phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
- Canonical SMILES
- CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)CO)F
- InChIKey
- XFALPSLJIHVRKE-GFCCVEGCSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.